MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    VALIDATING ACCELEROMETRY AS A MEASURE OF ENERGY EXPENDITURE AND PHYSICAL ACTIVITY IN ADULTS WITH HUNTINGTON’S DISEASE

    L. Simón, E. Cubo, J. Rivadeneyra, C. Collazo, M. Soto, J. Raya, D. Castillo, S. Calvo, A. Fernández (Burgos, Spain)

    Objective: to validate the use of accelerometers to quantify energy expenditure (EE) under controlled conditions for Huntington’s disease (HD) patients using Indirect Calorimetry (IC) as…
  • 2022 International Congress

    DNMT1 level and global DNA methylation in CD45+ blood cells in Parkinson’s disease

    A. Lavrinova, A. Zhuravlev, I. Miliukhina, E. Belykh, A. Tyurin, O. Berkovich, S. Pchelina, A. Emelyanov (Gatchina, Russian Federation)

    Objective: The aim of our study was to assess the alterations in DNA methyltransferase1 (DNMT1) level and global DNA methylation (5-mC) in CD45+ blood cells…
  • 2022 International Congress

    Antipsychotic use in Parkinson’s disease: a single center retrospective chart review

    S. Brooker, C. Yeh, D. Larson (Chicago, USA)

    Objective: To assess the prevalence of antipsychotic (AP) use in people with Parkinson’s disease (PwP), and identify factors associated with AP prescription and differences in…
  • 2022 International Congress

    Malignant catatonia secondary to clozapine withdrawal: A case report

    T. Thammongkolchai, P. Termsarasab (Bangkok, Thailand)

    Objective: To report a patient with malignant catatonia from abrupt clozapine discontinuation. Background: Clozapine blocks 5HT2A/5HT2C serotonin and dopamine receptors. Cholinergic and serotoninergic rebounds have…
  • 2022 International Congress

    Molecular alterations and pathological remodeling of colonic wall in patients with Parkinson’s disease

    G. Bellini, G. Palermo, D. Frosini, L. Benvenuti, C. Pellegrini, M. Bellini, N. Bernardini, M. Fornai, R. Ceravolo (Pisa, Italy)

    Objective: To evaluate, in an integrated manner, changes in faecal microbiota composition, morpho-functional alterations of the colonic mucosal barrier and changes of inflammatory markers in…
  • 2022 International Congress

    EPIDEMIOLOGY OF FUNCTIONAL MOVEMENT DISORDERS

    B. Yardimci Kara, N. Oksuz Gurlen, O. Dogu (Mersin, Turkey)

    Objective: Our study aims to report the frequency of patients with FMD and to describe their demographic and clinical data. The second aim of our…
  • 2022 International Congress

    NONINVASIVE BRAINSTEM MODULATION FOR THE TREATMENT OF NONMOTOR SYMPTOMS IN PARKINSON’S DISEASE: A RANDOMIZED CONTROLLED TRIAL AND OPEN LABEL EXTENSION STUDY

    K. Ade (Durham, USA)

    Objective: A multi-site double-blinded pivotal randomized controlled trial (RCT) with an open label extension (OLE) study has been initiated to evaluate the safety and efficacy…
  • 2022 International Congress

    The role of Parkinson Nurses for personalizing care in Parkinson’s Disease: a systematic review and meta-analysis

    J. Stümpel, M. van Munster, T. Mestre, D. Pedrosa (Cologne, Germany)

    Objective: To identify the various roles and functions that Parkinson Nurses (PNs) may hold for personalized care of Patients with Parkinson’s (PwPs). Providing a systematic…
  • 2022 International Congress

    Spectrum of Movement Disorder Emergencies in a Tertiary Care Centre in India: A prospective Observational Study

    A. Bhoyar, R. Yadav, P. Pal, R. Mahale, N. Kamble, V. Holla (BANGLORE, India)

    Objective: The objective of this study was to study the clinical phenomenology, investigational characteristics, radiological findings and the outcomes at discharge of patients presenting with…
  • 2022 International Congress

    Atypical parkinsonism presenting with isolated gaze palsy: implications for prognosis

    D. Damas, I. Carvalho, A. Jorge, I. Cunha, A. Morgadinho, J. Lemos, F. Moreira (Coimbra, Portugal)

    Objective: To present a case of atypical presentation of Progressive Supranuclear Palsy (PSP). Background: PSP is a clinical syndrome characterized by parkinsonism, supranuclear gaze palsy…
  • « Previous Page
  • 1
  • …
  • 149
  • 150
  • 151
  • 152
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley